+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

OTC Eyedrop Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137359
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The U.S. over-the-counter (OTC) eyedrop market is experiencing accelerated transformation, propelled by increasing demand for self-care solutions, evolving consumer behaviors, and sustained innovation from industry leaders. Decision-makers navigating this sector must understand both the shifting landscape and the pivotal trends that will influence market direction over the coming decade.

Market Snapshot: Over-the-Counter Eyedrop Industry

The U.S. OTC eyedrop market is positioned for robust expansion, anchored by a growing population experiencing ocular discomfort, heightened digital device use, and aging demographics. Market participants include established pharmaceutical companies, specialty manufacturers, and new entrants capitalizing on mounting consumer demand. The market’s growth is further supported by diversification of distribution channels and regulatory momentum streamlining product approvals. Manufacturers are adapting to rapidly changing dynamics by advancing product innovation and scaling omnichannel strategies to match rising expectations for immediate relief, convenience, and transparency.

Scope & Segmentation of the Over-the-Counter Eyedrop Market

This comprehensive report examines intricate segmentation, enabling stakeholders to target high-growth areas and optimize their strategies in the competitive OTC eyedrop market.

  • Product Types: Allergy relief (including ketotifen and naphazoline), anti-infective agents, artificial tears (preservative-free and with preservative), contact lens rewetting, and redness relief (naphazoline, oxymetazoline, tetrahydrozoline).
  • Distribution Channels: Grocery and retail networks (convenience stores, supermarkets), online vendors (e-tailers, manufacturer sites), and pharmacies (chain and independent).
  • Applications: Allergic conjunctivitis, contact lens rewetting, dry eye syndrome (aqueous deficient and evaporative), and eye redness management.
  • Formulation Types: Preservative-free and with-preservative solutions, each available in multi-dose and single-use formats.
  • Packaging Types: Multi-dose options (dropper bottles, pump sprays) and single-use unit dose vials for optimal portability and sterility.
  • Age Groups: Adults, pediatrics, and seniors, reflecting unique physiological and compliance needs.
  • Therapeutic Actions: Anti-infectives, antihistamines (ketotifen, olopatadine), decongestants, and lubricants, serving a spectrum of ocular conditions.
  • Regional Coverage: Americas (U.S. states, Canada, Brazil, others), EMEA (including UK, Germany, France, Middle East, Africa), and Asia-Pacific (such as China, India, Japan, Australia, Southeast Asia).
  • Key Players: AbbVie, Alcon, Johnson & Johnson Consumer, Bausch + Lomb, Rohto Pharmaceutical, Santen Pharmaceutical, Thea Pharma, CooperVision, Pfizer, and Novartis.

Key Takeaways for Market Stakeholders

  • Patient demand for preservative-free and multifunctional formulations is shaping product innovation, with advanced delivery systems supporting adherence and user feedback.
  • Consumer shifts toward digital engagement and telehealth are driving a move from traditional retail to multi-channel and direct-to-consumer platforms, prompting firms to refine omnichannel strategies.
  • Sustainability targets are transforming packaging, with investments in recyclable materials and reduced-waste vials aligning with environmental values and corporate responsibility efforts.
  • Real-time analytics and cloud-based solutions are enhancing supply chain visibility, enabling responsive demand forecasting and supporting continuous inventory optimization.
  • Distinct regional trends reveal opportunities: the Americas benefit from advanced retail networks and strong spending power, EMEA emphasizes premium positioning and compliance, and Asia-Pacific blends innovation with local preferences.
  • Leading companies deploy data-driven marketing, strategic alliances with technology providers, and educational outreach to build consumer trust and fuel competitive differentiation.

Tariff Impact on U.S. OTC Eyedrop Market

Recent tariff policies introduced in 2025 have increased costs for imported active ingredients and packaging, pushing manufacturers to shift sourcing strategies and invest in domestic production partnerships. These changes are prompting both price recalibrations and regional manufacturing reevaluations, with supply chain agility now critical. Distributors and retailers are adapting through renegotiated contract terms and dynamic pricing, driving deeper industry collaboration and investment in localized capabilities for supply resilience.

Methodology & Data Sources

The findings are based on a dual data approach: primary insights from interviews with industry professionals, ophthalmologists, and regulatory experts, and quantitative surveys among distributors, retailers, and end-users. Secondary research includes peer-reviewed publications, regulatory documents, patent databases, and corporate disclosures. Stringent quality controls verify data integrity to ensure actionable insights.

Why This Report Matters: Strategic Value for Decision-Makers

  • Guides leaders in identifying new-growth vectors, product opportunities, and risk factors in the competitive OTC eyedrop landscape.
  • Empowers operational and regulatory planning, supporting stakeholders in adapting sourcing, manufacturing, and compliance strategies amid evolving market and tariff conditions.
  • Highlights actionable insights on consumer, formulation, and regional trends, enabling evidence-based investment and portfolio decisions.

Conclusion

As the U.S. OTC eyedrop market enters a new era of innovation, operational agility, and patient focus, stakeholders equipped with these strategic insights are well positioned to secure sustainable growth and resilient market leadership.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing demand for preservative-free lubricating eyedrops among sensitive eyes consumers
5.2. Introduction of dual-action antihistamine and decongestant eyedrops to improve allergy relief efficacy
5.3. Surge in e-commerce sales channels driving direct-to-consumer marketing for over-the-counter eyedrop brands nationwide
5.4. Increased investment in nanotechnology formulations to enhance ocular drug delivery performance and comfort
5.5. Rising consumer awareness campaigns highlighting the risks of prolonged red-eye eyedrop misuse without medical consultation
5.6. Regulatory push for standardized efficacy and safety labeling leading to reformulation by major over-the-counter eyedrop manufacturers
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. OTC Eyedrop Market, by Product Type
8.1. Introduction
8.2. Allergy Relief
8.2.1. Ketotifen
8.2.2. Naphazoline
8.3. Anti Infective
8.4. Artificial Tears
8.4.1. Preservative Free
8.4.2. With Preservative
8.5. Contact Lens Rewetting
8.6. Redness Relief
8.6.1. Naphazoline
8.6.2. Oxymetazoline
8.6.3. Tetrahydrozoline
9. OTC Eyedrop Market, by Distribution Channel
9.1. Introduction
9.2. Grocery & Retail
9.2.1. Convenience Stores
9.2.2. Supermarkets
9.3. Online
9.3.1. E Tailers
9.3.2. Manufacturer Sites
9.4. Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. OTC Eyedrop Market, by Application
10.1. Introduction
10.2. Allergic Conjunctivitis
10.3. Contact Lens Rewetting
10.4. Dry Eye Syndrome
10.4.1. Aqueous Deficient
10.4.2. Evaporative Dry Eye
10.5. Eye Redness
11. OTC Eyedrop Market, by Formulation Type
11.1. Introduction
11.2. Preservative Free
11.2.1. Multi Dose
11.2.2. Single Use
11.3. With Preservative
11.3.1. Multi Dose
11.3.2. Single Use
12. OTC Eyedrop Market, by Packaging Type
12.1. Introduction
12.2. Multi Dose
12.2.1. Dropper Bottle
12.2.2. Pump Spray
12.3. Single Use
12.3.1. Unit Dose Vial
13. OTC Eyedrop Market, by Age Group
13.1. Introduction
13.2. Adults
13.3. Pediatrics
13.4. Seniors
14. OTC Eyedrop Market, by Therapeutic Action
14.1. Introduction
14.2. Anti Infectives
14.3. Antihistamines
14.3.1. Ketotifen
14.3.2. Olopatadine
14.4. Decongestants
14.5. Lubricants
15. Americas OTC Eyedrop Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa OTC Eyedrop Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific OTC Eyedrop Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. AbbVie Inc.
18.3.2. Alcon Inc.
18.3.3. Johnson & Johnson Consumer Inc.
18.3.4. Bausch + Lomb Corporation
18.3.5. Rohto Pharmaceutical Co., Ltd.
18.3.6. Santen Pharmaceutical Co., Ltd.
18.3.7. Thea Pharma Group S.A.S.
18.3.8. CooperVision LLC
18.3.9. Pfizer Inc.
18.3.10. Novartis International AG
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. OTC EYEDROP MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OTC EYEDROP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OTC EYEDROP MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OTC EYEDROP MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OTC EYEDROP MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES OTC EYEDROP MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES OTC EYEDROP MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC OTC EYEDROP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. OTC EYEDROP MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. OTC EYEDROP MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. OTC EYEDROP MARKET: RESEARCHAI
FIGURE 30. OTC EYEDROP MARKET: RESEARCHSTATISTICS
FIGURE 31. OTC EYEDROP MARKET: RESEARCHCONTACTS
FIGURE 32. OTC EYEDROP MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OTC EYEDROP MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OTC EYEDROP MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OTC EYEDROP MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OTC EYEDROP MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OTC EYEDROP MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OTC EYEDROP MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OTC EYEDROP MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OTC EYEDROP MARKET SIZE, BY KETOTIFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OTC EYEDROP MARKET SIZE, BY KETOTIFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OTC EYEDROP MARKET SIZE, BY NAPHAZOLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OTC EYEDROP MARKET SIZE, BY NAPHAZOLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OTC EYEDROP MARKET SIZE, BY CONTACT LENS REWETTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OTC EYEDROP MARKET SIZE, BY CONTACT LENS REWETTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OTC EYEDROP MARKET SIZE, BY NAPHAZOLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OTC EYEDROP MARKET SIZE, BY NAPHAZOLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OTC EYEDROP MARKET SIZE, BY OXYMETAZOLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OTC EYEDROP MARKET SIZE, BY OXYMETAZOLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OTC EYEDROP MARKET SIZE, BY TETRAHYDROZOLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OTC EYEDROP MARKET SIZE, BY TETRAHYDROZOLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OTC EYEDROP MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OTC EYEDROP MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OTC EYEDROP MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OTC EYEDROP MARKET SIZE, BY SUPERMARKETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OTC EYEDROP MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OTC EYEDROP MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OTC EYEDROP MARKET SIZE, BY E TAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OTC EYEDROP MARKET SIZE, BY E TAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OTC EYEDROP MARKET SIZE, BY MANUFACTURER SITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OTC EYEDROP MARKET SIZE, BY MANUFACTURER SITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OTC EYEDROP MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OTC EYEDROP MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OTC EYEDROP MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OTC EYEDROP MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OTC EYEDROP MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OTC EYEDROP MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OTC EYEDROP MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OTC EYEDROP MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OTC EYEDROP MARKET SIZE, BY CONTACT LENS REWETTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OTC EYEDROP MARKET SIZE, BY CONTACT LENS REWETTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OTC EYEDROP MARKET SIZE, BY AQUEOUS DEFICIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OTC EYEDROP MARKET SIZE, BY AQUEOUS DEFICIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OTC EYEDROP MARKET SIZE, BY EVAPORATIVE DRY EYE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OTC EYEDROP MARKET SIZE, BY EVAPORATIVE DRY EYE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OTC EYEDROP MARKET SIZE, BY EYE REDNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OTC EYEDROP MARKET SIZE, BY EYE REDNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL OTC EYEDROP MARKET SIZE, BY DROPPER BOTTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL OTC EYEDROP MARKET SIZE, BY DROPPER BOTTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL OTC EYEDROP MARKET SIZE, BY PUMP SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL OTC EYEDROP MARKET SIZE, BY PUMP SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL OTC EYEDROP MARKET SIZE, BY UNIT DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL OTC EYEDROP MARKET SIZE, BY UNIT DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL OTC EYEDROP MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL OTC EYEDROP MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL OTC EYEDROP MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL OTC EYEDROP MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL OTC EYEDROP MARKET SIZE, BY SENIORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL OTC EYEDROP MARKET SIZE, BY SENIORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL OTC EYEDROP MARKET SIZE, BY KETOTIFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL OTC EYEDROP MARKET SIZE, BY KETOTIFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL OTC EYEDROP MARKET SIZE, BY OLOPATADINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL OTC EYEDROP MARKET SIZE, BY OLOPATADINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL OTC EYEDROP MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL OTC EYEDROP MARKET SIZE, BY DECONGESTANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL OTC EYEDROP MARKET SIZE, BY LUBRICANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL OTC EYEDROP MARKET SIZE, BY LUBRICANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS OTC EYEDROP MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS OTC EYEDROP MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES OTC EYEDROP MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES OTC EYEDROP MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 221. CANADA OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 224. CANADA OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 225. CANADA OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 226. CANADA OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 227. CANADA OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 228. CANADA OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 229. CANADA OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. CANADA OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. CANADA OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 232. CANADA OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 233. CANADA OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 234. CANADA OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 235. CANADA OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. CANADA OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. CANADA OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. CANADA OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. CANADA OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 240. CANADA OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 241. CANADA OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 242. CANADA OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 243. CANADA OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 244. CANADA OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 245. CANADA OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 246. CANADA OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 247. CANADA OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 248. CANADA OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 249. CANADA OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 250. CANADA OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 251. CANADA OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 252. CANADA OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 253. CANADA OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. CANADA OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. CANADA OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2018-2024 (USD MILLION)
TABLE 256. CANADA OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2025-2030 (USD MILLION)
TABLE 257. CANADA OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2018-2024 (USD MILLION)
TABLE 258. CANADA OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 262. MEXICO OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 263. MEXICO OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 264. MEXICO OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 265. MEXICO OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 266. MEXICO OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 267. MEXICO OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. MEXICO OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. MEXICO OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 270. MEXICO OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 271. MEXICO OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 272. MEXICO OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 273. MEXICO OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. MEXICO OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. MEXICO OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. MEXICO OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. MEXICO OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 278. MEXICO OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 279. MEXICO OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 280. MEXICO OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 281. MEXICO OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 282. MEXICO OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 283. MEXICO OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 284. MEXICO OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 285. MEXICO OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 286. MEXICO OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 287. MEXICO OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. MEXICO OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. MEXICO OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2018-2024 (USD MILLION)
TABLE 294. MEXICO OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2025-2030 (USD MILLION)
TABLE 295. MEXICO OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2018-2024 (USD MILLION)
TABLE 296. MEXICO OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTION, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2018-2024 (USD MILLION)
TABLE 334. BRAZIL OTC EYEDROP MARKET SIZE, BY ANTIHISTAMINES, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA OTC EYEDROP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA OTC EYEDROP MARKET SIZE, BY ALLERGY RELIEF, 2025-2030 (USD MILLION)
TABLE 339. ARGENTINA OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2018-2024 (USD MILLION)
TABLE 340. ARGENTINA OTC EYEDROP MARKET SIZE, BY ARTIFICIAL TEARS, 2025-2030 (USD MILLION)
TABLE 341. ARGENTINA OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2018-2024 (USD MILLION)
TABLE 342. ARGENTINA OTC EYEDROP MARKET SIZE, BY REDNESS RELIEF, 2025-2030 (USD MILLION)
TABLE 343. ARGENTINA OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. ARGENTINA OTC EYEDROP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. ARGENTINA OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2018-2024 (USD MILLION)
TABLE 346. ARGENTINA OTC EYEDROP MARKET SIZE, BY GROCERY & RETAIL, 2025-2030 (USD MILLION)
TABLE 347. ARGENTINA OTC EYEDROP MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 348. ARGENTINA OTC EYEDROP MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 349. ARGENTINA OTC EYEDROP MARKET SIZE, BY PHARMACY, 2018-2024 (USD MILLION)
TABLE 350. ARGENTINA OTC EYEDROP MARKET SIZE, BY PHARMACY, 2025-2030 (USD MILLION)
TABLE 351. ARGENTINA OTC EYEDROP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 352. ARGENTINA OTC EYEDROP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 353. ARGENTINA OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
TABLE 354. ARGENTINA OTC EYEDROP MARKET SIZE, BY DRY EYE SYNDROME, 2025-2030 (USD MILLION)
TABLE 355. ARGENTINA OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 356. ARGENTINA OTC EYEDROP MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 357. ARGENTINA OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2018-2024 (USD MILLION)
TABLE 358. ARGENTINA OTC EYEDROP MARKET SIZE, BY PRESERVATIVE FREE, 2025-2030 (USD MILLION)
TABLE 359. ARGENTINA OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2018-2024 (USD MILLION)
TABLE 360. ARGENTINA OTC EYEDROP MARKET SIZE, BY WITH PRESERVATIVE, 2025-2030 (USD MILLION)
TABLE 361. ARGENTINA OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 362. ARGENTINA OTC EYEDROP MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 363. ARGENTINA OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 364. ARGENTINA OTC EYEDROP MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 365. ARGENTINA OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
TABLE 366. ARGENTINA OTC EYEDROP MARKET SIZE, BY SINGLE USE, 2025-2030 (USD MILLION)
TABLE 367. ARGENTINA OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 368. ARGENTINA OTC EYEDROP MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 369. ARGENTINA OTC EYEDROP MARKET SIZE, BY THERAPEUTIC ACTIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this OTC Eyedrop market report include:
  • AbbVie Inc.
  • Alcon Inc.
  • Johnson & Johnson Consumer Inc.
  • Bausch + Lomb Corporation
  • Rohto Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Thea Pharma Group S.A.S.
  • CooperVision LLC
  • Pfizer Inc.
  • Novartis International AG